Adalimumab is an effective option in the treatment of patients with refractory rheumatoid arthritis

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.21, Iss.4, 2005-04, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab effective for juvenile rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

By Poddubnyy Denis Rudwaleit Martin

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab a PREMIER treatment for early rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Strategies for the Prevention and Treatment of Osteoporosis in Patients with Rheumatoid Arthritis

By Phillips Kristine Aliprantis Antonios Coblyn Jonathan

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 773-779

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH Toonen Erik JM Scheffer Hans Radstake Timothy RDJ Barrera Pilar Franke Barbara

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite